GlobeNewswire

NRT & Sightline Secure Multi-Year Exclusive Agreement with Ocean Resort Casino

Dela

Atlantic City's newest resort casino opens with a seamless customer experience for omni-channel solutions

 

LAS VEGAS, July 12, 2018 (GLOBE NEWSWIRE) -- NRT Technology Corp. and Sightline Payments, LLC (together "NRT Sightline") today announced that Ocean Resort Casino in Atlantic City, N.J. opened its doors with the full suite of NRT Sightline solutions, including Play+, QJ self-serve kiosks, Cash+ ATM, credit and debit advances, VisuaLimits table signs and analytics, and the full suite of NCC credit and compliance solutions.

"NRT Sightline has invested in cutting-edge technology that gives us a competitive advantage, and we look forward to our long-term partnership with this world-class technology leader," said Alan Greenstein, Chief Financial Officer of Ocean Resort Casino.

"Ocean Resort Casino is Atlantic City's showcase property for a truly omni-channel guest experience.  As the lines that separate cash and cashless commerce converge in gaming, our solutions remove friction from the payments experience for guests, allowing operators like Ocean to focus on delivering a great customer experience," said John Dominelli, NRT's Founder and CEO

NRT Sightline believes that gaming operators and their technology partners need to be aligned through collaboration and innovation, and nowhere does this hold truer than in the realm of commerce and payments. Gaming operators must continue to deliver traditional cash-based solutions, while simultaneously offer new ways for patrons engage through mobile payments and value-added cashless solutions.  NRT Sightline is focused on transforming what has traditionally been a cash-based industry, bringing a new approach to payments that has allowed millions of gaming patrons to easily and securely transact in new and innovative ways.

"We are the undisputed leader in driving mobile commerce and customer engagement experiences across sports betting, slots, tables, or any online or in-person game of choice," said Kirk Sanford, Founder and CEO of Sightline. "Ocean Casino Resort has a vision of enhancing the overall guest experience by offering new and unique ways to wager and make purchases, and our next gen payments solutions align perfectly with that vision."

The partnership between NRT Sightline and Ocean Resort Casino encompass the following solutions:

  • Play+(TM): Reduce payments friction with the next generation of cashless, mobile, and omni-channel payments solutions for your integrated resort.
  • QJ Self-Serve Kiosks: The latest in self-serve kiosk automation and the casino industry's sexiest, most advanced, reliable and secure casino cash handling & payment kiosk available. Our 9-in-1 platform supports a broad range of services including ticket redemption, bill breaking, ATM (with Transaction Rescue), credit and debit advance, dynamic currency conversion, e-check cashing, Play+, and more.
  • Cash+ ATM, Credit & Debit Processing: Guests can easily, quickly, and securely complete ATM, credit and debit cash advance, and check cashing transaction at the NEO kiosk or stand-alone ATM. Our Transaction Rescue feature is proven to complete more guest transactions.
  • VisuaLimits(TM):  An intelligent 17-in-1 digital table game platform with a two-sided LCD screen providing guest engagement and actionable insights for table game staff, including bet recognition, digital payments, dealer performance, time and attendance, intelligent limits, surveillance, and player rating integration
  • NCC Gaming(TM): A cloud based FCRA compliant end-to-end marker management solution for online application hosting, credit acceptance, underwriting, maintenance, marker issuance, deposit and collection.
  • NCC AML Compliance(TM): Assists operators in achieving Title 31/AML compliance requirements by seamlessly integrating with casino management systems and cash-access touchpoints. This innovative solution offers Multiple Transaction Log (MTL), Negotiable Instrument Log (NIL) and Monetary Instruments Log (MIL) compiling and reporting capabilities, and seamless integrations to allow for the electronic submission of CTR and SAR forms.
  • HABIT(TM) Analytics: Powered by GamingAnalytics.ai is a search driven analytics tool for casinos that uses AI, machine learning, and natural language processing on any data source. Import your gaming and payments data into our cognitive computing platform and then just ask Habit a question about your business and we will generate relevant, context aware insights and recommendations.

About Ocean Resort Casino

As the tallest building in Atlantic City, the landmark Ocean Resort Casino offers unparalleled ocean views in its 1,399 rooms and capture the essence of what draws people to this popular waterfront destination situated on 20 acres along the city's famed Boardwalk.  In addition to its expansive hotel, casino and meeting space, Ocean Resort Casino will feature six swimming pools, including a saltwater pool, a cabana filled sun-deck and distinctive dining and entertainment venues.   Ocean Resort Casino is part of The Unbound Collection by Hyatt Portfolio and will include a 32,000 square-foot onsite exhale spa. Ocean Resort Casino is owned and operated by Ocean Walk LLC.  For more information visit www.theoceanac.com

About NRT & Sightline

On closing of the pending merger between NRT and Sightline (subject to regulatory approval), NRT Sightline will be the global leader in the design and development of enterprise platforms for the gaming industry, including current and next generation payment systems, specialized self-serve financial/marketing kiosks, big data analytics utilizing artificial intelligence and gamification, credit marker information services, and digital and mobile experiences. Through our global family of companies, we enable more than 1 billion physical and digital commerce experiences at over 750 casino properties worldwide, including the top 25 largest casino corporations.  By seamlessly combining technological innovation with strategic partnerships, our companies create the most convenient, reliable, and secure omni-channel payment ecosystem for casino operators and their guests. NRT and Sightline have been recognized with numerous industry awards, including the coveted "Most Innovative Gaming Technology Product of the Year" for our Play+(TM) cloud-based cashless funding platform. Our collective solutions are used by casinos, lotteries, race and sports, banking & retailers around the world.

For further information about this acquisition, please contact:  Michael Dominelli, NRT's SVP Marketing at mdominelli@nrttech.com

For more information about Sightline or its pending merger with NRT, please contact:  Omer Sattar, Sightline's EVP Strategic Relationships at osattar@sightlinepayments.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NRT Sightline via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

Karolinska Development's portfolio company Aprea presents promising results with APR-246 in combination with immuno-oncology agents3.4.2019 14:00:00 CESTPressmeddelande

STOCKHOLM, April 3, 2019. Karolinska Development's portfolio company Aprea today presents results from studies with APR-246 in combination with immune checkpoint blockade. The results show that APR-246 can improve the effect of immuno-oncology agents. Karolinska Development portfolio company Aprea Therapeutics announced today the results of studies with APR-246 in combination with immune checkpoint blockade. The results were presented by researchers from Memorial Sloan Kettering Cancer Center at the 2019 AACR Annual Meeting in Atlanta. The studies collectively support a role for p53 activity in the tumor microenvironment and suggest that stabilization of the tumor suppressor protein, p53, by APR-246 can enhance anti-tumor immune response, particularly when combined with immuno-oncology agents. The studies characterized changes in the tumor immune microenvironment in melanoma and colorectal cancer in vivo models when treated with APR-246 and immuno-oncology agents, either alone or in co

Karolinska Development's portfolio company Aprea presents promising results with APR-246 in combination with immuno-oncology agents3.4.2019 14:00:00 CESTPressmeddelande

STOCKHOLM, April 3, 2019. Karolinska Development's portfolio company Aprea today presents results from studies with APR-246 in combination with immune checkpoint blockade. The results show that APR-246 can improve the effect of immuno-oncology agents. Karolinska Development portfolio company Aprea Therapeutics announced today the results of studies with APR-246 in combination with immune checkpoint blockade. The results were presented by researchers from Memorial Sloan Kettering Cancer Center at the 2019 AACR Annual Meeting in Atlanta. The studies collectively support a role for p53 activity in the tumor microenvironment and suggest that stabilization of the tumor suppressor protein, p53, by APR-246 can enhance anti-tumor immune response, particularly when combined with immuno-oncology agents. The studies characterized changes in the tumor immune microenvironment in melanoma and colorectal cancer in vivo models when treated with APR-246 and immuno-oncology agents, either alone or in co

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum